Preliminary reports reveal conolidine may possibly inhibit distinct ion channels, cutting down neuronal excitability and restricting pain indicators. This mechanism is particularly relevant in neuropathic ache, wherever abnormal signaling triggers persistent soreness. Moreover, conolidine appears to influence G protein-coupled receptor (GPCR) pathw